The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...

Bronchiolitis remains the leading cause of hospital admission in infancy and of paediatric intensive care unit use.1 Management of bronchiolitis has been largely limited to supportive care, reflecting ...

Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...

High-frequency oscillatory ventilation (HFOV) reduced bronchopulmonary dysplasia in preterm infants with neonatal respiratory ...

CARBONIC anhydrase is a zinc metalloenzyme that reversibly catalyzes the hydration of carbon dioxide to bicarbonate and hydrogen ions according to the following equation 1: Blood was obtained from ...

Prenatal exposure to air pollution increases the risk of severe respiratory distress in newborn babies, according to new research conducted at the Penn State College of Medicine in collaboration with ...

Prenatal exposure to air pollution increases the risk of severe respiratory distress in newborn babies, according to new research. The risk increases with exposure specifically to fine particulate ...

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed ...

THE respiratory-distress syndrome, or hyalinemembrane disease, is the commonest cause of death among newborn, especially premature, infants, and yet its pathogenesis remains a mystery and its ...

Infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves ...

Studies in which montelukast was given to infants with bronchiolitis during the acute phase of illness and for 8 weeks afterward did not show any consistent benefit of the drug. In the Tucson ...